Please login to the form below

Not currently logged in
Email:
Password:

Actavis expands in Ireland

Generics manufacturer Actavis plans to boost its presence in Ireland, creating up to 25 new jobs and launching more than 120 generic drugs

Generics manufacturer Actavis plans to boost its presence in Ireland, creating up to 25 new jobs over the next five years and launching more than 120 generic drugs in the country. The company's chemotherapy treatment, gemcitabine, was made available to the Irish market on March 9 as Eli Lilly's patent for Gemzar expired in the European Union. 

With headquarters in Iceland the Actavis group employs about 11,000 people and has a presence in 40 countries. The group continues to grow and has acquired more than 20 companies in the past seven years including the human generics business of Alpharma in December 2005.

In a statement Tony Hynds, managing director of Actavis Ireland said: "Over the next five years, we plan to rapidly expand our offering in Ireland in all channels – hospital-specific, prescription and over-the-counter medicines." 

In Febuary 2009 the Irish Government published the report Economies in Drug Usage in the Irish Healthcare Setting which promotes generic prescribing as part of a strategy to reduce the country's healthcare spend.

17th March 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics